ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 637411 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 637411; 2) Community: the network communities that were significantly associated with the response to NSC 637411; 3) Molecule: the relationships between components within communities and NSC 637411; 4) MDR: the compounds that were significantly associated with the NSC 637411.

NSC Compound Enrichment Correlation
NSC 724628 4,11-bis[[2-(dimethylamino)ethyl]-amino]-1H-naphtho[2,3-f]in dole-5,10-dione 0.0247979034812109 0.13840825
NSC 727049 11-(6'-Aminohexylidene]-5,6-dihydro-5-keto-2,3-dimethoxy-6-m ethyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinoline 0.0247979034812109 -0.041311875
NSC 746087 1-(7-Fluoro-3-methyl-quinoxalin-2-yl)-3-(3,4,5-trimethoxy-phenyl)-propenone 0.0247979034812109 0.17053702
NSC 758662 Lovastatin [USAN] 0.0247979034812109 0.0014491738
NSC 78714 Clothixamide maleate (USAN) 0.0247979034812109 0.37114581
NSC 106486 Formycin B 0.0247979034812111 0.19296825
NSC 146268 as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- 0.0247979034812111 0.22507726
NSC 305767 2,4-Quinazolinediamine, 6-[(4-chlorophenyl)thio]- 0.0247979034812111 0.35817237
NSC 337851 Pregna-1,4-diene-3,11,20-trione, 21-[[[[3,6-bis(dimethylamino)-9-acridinyl]thio]acetyl]oxy]-17-hydroxy- 0.0247979034812111 0.19018438
NSC 625507 Null 0.0247979034812111 0.040145518
Total:92  Current:56    [First] [Prev] [Next] [Last]